Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CILASTATIN\IMIPENEM Cause Rash maculo-papular? 82 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Rash maculo-papular have been filed in association with CILASTATIN\IMIPENEM. This represents 1.7% of all adverse event reports for CILASTATIN\IMIPENEM.

82
Reports of Rash maculo-papular with CILASTATIN\IMIPENEM
1.7%
of all CILASTATIN\IMIPENEM reports
1
Deaths
48
Hospitalizations

How Dangerous Is Rash maculo-papular From CILASTATIN\IMIPENEM?

Of the 82 reports, 1 (1.2%) resulted in death, 48 (58.5%) required hospitalization, and 1 (1.2%) were considered life-threatening.

Is Rash maculo-papular Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CILASTATIN\IMIPENEM. However, 82 reports have been filed with the FAERS database.

What Other Side Effects Does CILASTATIN\IMIPENEM Cause?

Epilepsy (615) Product use in unapproved indication (385) Drug ineffective (321) Delirium (309) Off label use (248) Pyrexia (168) Seizure (155) Nausea (145) Vomiting (133) Diarrhoea (122)

What Other Drugs Cause Rash maculo-papular?

SULFAMETHOXAZOLE\TRIMETHOPRIM (935) AMOXICILLIN (871) VANCOMYCIN (642) PIPERACILLIN\TAZOBACTAM (629) PANTOPRAZOLE (589) LAMOTRIGINE (568) ALLOPURINOL (550) CARBOPLATIN (529) ACETAMINOPHEN (499) CLINDAMYCIN (484)

Which CILASTATIN\IMIPENEM Alternatives Have Lower Rash maculo-papular Risk?

CILASTATIN\IMIPENEM vs CILAZAPRIL ANHYDROUS CILASTATIN\IMIPENEM vs CILGAVIMAB\TIXAGEVIMAB CILASTATIN\IMIPENEM vs CILOSTAZOL CILASTATIN\IMIPENEM vs CILTACABTAGENE AUTOLEUCEL CILASTATIN\IMIPENEM vs CIMETIDINE

Related Pages

CILASTATIN\IMIPENEM Full Profile All Rash maculo-papular Reports All Drugs Causing Rash maculo-papular CILASTATIN\IMIPENEM Demographics